Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $15.0 million.

  • Cumberland Pharmaceuticals' Shares Outstanding (Diluted Average) rose 616.8% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 616.8%. This contributed to the annual value of $14.1 million for FY2024, which is 166.8% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Shares Outstanding (Diluted Average) stood at $15.0 million for Q3 2025, which was up 616.8% from $15.3 million recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Shares Outstanding (Diluted Average) ranged from a high of $15.3 million in Q2 2025 and a low of $14.1 million during Q4 2024
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $14.6 million (2022), whereas its average is $14.7 million.
  • In the last 5 years, Cumberland Pharmaceuticals' Shares Outstanding (Diluted Average) plummeted by 362.45% in 2022 and then surged by 824.09% in 2025.
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $14.9 million in 2021, then fell by 2.29% to $14.6 million in 2022, then decreased by 1.82% to $14.3 million in 2023, then decreased by 1.67% to $14.1 million in 2024, then rose by 6.39% to $15.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $15.0 million for Q3 2025, versus $15.3 million for Q2 2025 and $15.3 million for Q1 2025.